Germline PTPN13 mutations in patients with bone marrow failure and acute lymphoblastic leukemia

Affiliations

• ¹ Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.
• ² Departmento Bioquímica y Biología Molecular, Universidad de Salamanca, 37008, Salamanca, Spain.
• ³ IBSAL (Instituto de Investigacion Biomedica de Salamanca), 37007, Salamanca, Spain.
• ⁴ Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada.
• ⁵ The Blood and Marrow Transplant, Hematology-Oncology Department, Dana-Dwek Children's Hospital, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
• ⁶ Boston Children's Hospital, Boston, MA, USA.
• ⁷ Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
• ⁸ McLaughlin Centre, University of Toronto, Toronto, ON, Canada.
• ⁹ Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
• ¹⁰ Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada. yigal.dror@sickkids.ca.
• ¹¹ Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada. yigal.dror@sickkids.ca.
• ¹² Institute of Medical Science, University of Toronto, Toronto, ON, Canada. yigal.dror@sickkids.ca.